(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 18.61% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.88%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.63%.
Dyadic International's revenue in 2025 is $4,135,078.On average, 1 Wall Street analysts forecast DYAI's revenue for 2025 to be $166,463,871, with the lowest DYAI revenue forecast at $166,463,871, and the highest DYAI revenue forecast at $166,463,871. On average, 1 Wall Street analysts forecast DYAI's revenue for 2026 to be $199,032,889, with the lowest DYAI revenue forecast at $199,032,889, and the highest DYAI revenue forecast at $199,032,889.
In 2027, DYAI is forecast to generate $253,314,586 in revenue, with the lowest revenue forecast at $253,314,586 and the highest revenue forecast at $253,314,586.